BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOLFree Report) in a research report released on Wednesday morning. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Down 7.7 %

Shares of BIOLASE stock opened at $0.01 on Wednesday. BIOLASE has a 12-month low of $0.02 and a 12-month high of $1.94. The stock has a market cap of $300,663.00, a P/E ratio of 0.00 and a beta of 0.67. The business’s 50 day moving average is $0.01 and its 200-day moving average is $0.02.

About BIOLASE

(Get Free Report)

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.

Featured Stories

Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.